⼈⼯内⽿システムのパイオニア･豪コクレア社の⽇本法⼈、株式会社⽇本コクレア（本社：東京都⽂京区、 執行役員社⻑：上中 茂弘、以下 ⽇本コクレア）は、「Cochlear™ Nucleus(R) 8 サウンドプロセッサ」を 2023 年 10 月 2 日より販売を開始いたします。

[画像1: https://prtimes.jp/i/79047/42/resize/d79047-42-277c0f5ae9068047b46e-0.jpg] 人工内⽿システムのパイオニア・豪コクレア社の日本法人 ...

Xinyu Li, General Manager, Greater China, Cochlear, explains the next generation technology has completely reimagined the internal components of the hearing device: "There are more than 10 years of ...

Cochlear Limited, the global leader in implantable hearing solutions, announced the US Food and Drug Administration (FDA) approval of the Cochlear Nucleus Nexa System – the world’s first and only, ...

Until now, recipients of cochlear implants have been limited to accessing new technology through the external part of their cochlear implant system – the sound processor – and have typically needed a ...

Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® ...

Cochlear has unveiled its latest hearing implant, the Nucleus Nexa, with one standout feature: the ability to upgrade its 'firmware', the software built into the device that controls how it works.